---
figid: PMC7016717__cancers-12-00019-g002
figtitle: Janus kinase 1 (JAK1)/STAT3 signaling in DLBCL
organisms:
- NA
pmcid: PMC7016717
filename: cancers-12-00019-g002.jpg
figlink: pmc/articles/PMC7016717/figure/cancers-12-00019-f002/
number: F2
caption: The role of Janus kinase 1 (JAK1)/STAT3 signaling in DLBCL. In ABC DLBCL,
  JAK1 and STAT3 are constitutively activated by autocrine production of IL-6 and/or
  IL-10 as a result of MYD88 mutations (mainly L265P) and other NF-κB activation mechanisms.
  Constitutive activation of JAK1 and STAT3 promotes cell survival and proliferation,
  modulates the tumor microenvironment and promotes tumor immune evasion through the
  canonical STAT3 pathway as well as the noncanonical chromatin modification mechanism
  by JAK1 (see details in the text).
papertitle: STAT3 Activation and Oncogenesis in Lymphoma.
reftext: Fen Zhu, et al. Cancers (Basel). 2020 Jan;12(1):19.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9227539
figid_alias: PMC7016717__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7016717__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7016717__cancers-12-00019-g002.html
  '@type': Dataset
  description: The role of Janus kinase 1 (JAK1)/STAT3 signaling in DLBCL. In ABC
    DLBCL, JAK1 and STAT3 are constitutively activated by autocrine production of
    IL-6 and/or IL-10 as a result of MYD88 mutations (mainly L265P) and other NF-κB
    activation mechanisms. Constitutive activation of JAK1 and STAT3 promotes cell
    survival and proliferation, modulates the tumor microenvironment and promotes
    tumor immune evasion through the canonical STAT3 pathway as well as the noncanonical
    chromatin modification mechanism by JAK1 (see details in the text).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL6
  - IL10
  - NFKB1
  - JAK1
  - MYD88
  - STAT3
  - DEFA1
  - CBX5
  - DEFA1B
  - SOCS3
  - NFKB2
  - RELA
  - RELB
  - REL
  - NFKBIA
  - NFKBIZ
  - BATF
  - BCL2
  - MCL1
  - BCL2A1
  - AKT2
  - SGK1
  - CD274
  - HCK
  - MEF2B
  - BORCS8-MEF2B
  - IRF4
  - EGR1
  - JUN
  - JUNB
  - JUND
  - MYC
  - tumor
---
